Rationale and study design of a trial to assess rTMS add-on value for the amelioration of negative symptoms of schizophrenia (RADOVAN)

URN to cite this document:: urn:nbn:de:bvb:355-epub-585387
DOI to cite this document:: 10.5283/epub.58538

Hebel, Tobias

; Langguth, Berthold

; Schecklmann, Martin

; Schoisswohl, Stefan

; Staudinger, Susanne ; Schiller, Alexander ; Ustohal, L. ; Sverak, T. ; Horky, M. ; Kasparek, T. ; Skront, T. ; Hyza, M. ; Poeppl, T.B. ; Riester, M.L. ; Schwemmer, L. ; Zimmermann, Steffen ; Sakreida, Katrin

License: Creative Commons Attribution Non-commercial No Derivatives 4.0
PDF - Published Version
(410kB)

Date of publication of this fulltext: 27 Jun 2024 08:06

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background Schizophrenia is a severe and often difficult to treat psychiatric illness. In many patients, negative symptoms dominate the clinical picture. Meta-analysis has suggested moderate, but significant effects of high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) on these symptoms. For treatment of depression a much shorter protocol - intermittent theta burst ...